In the original publication [1], the Informed Consent Statement was incorrectly stated as “Not applicable”. Since the study involved human participants, a correction has been made to update and clarify the Informed Consent Statement. The updated declaration has now been added in the Informed Consent Statement to explicitly state that informed consent was obtained from all participants involved in the study. This correction was approved by the Academic Editor. The original publication has also been updated.
The added statement is as follows:
Informed consent was obtained from the patient involved in the article.
Reference
- Ramos Peñafiel, C.O.; Martínez Tovar, A.; Pérez Sámano, D.; Cerón Maldonado, R.; Gallardo Rodríguez, A.G.; Martínez Murillo, C.; Olarte Carrillo, I. Effect of ABCB1 Expression on Measurable Residual Disease in Adult Patients with Acute Lymphoblastic Leukemia. Lymphatics 2025, 3, 6. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).